Literature DB >> 12071841

Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress.

Amanda C Fensome1, Michelle Josephs, Matilda Katan, Fernando Rodrigues-Lima.   

Abstract

DT40 cells have approx. 10-fold higher Mg2+-dependent neutral sphingomyelinase (NSM) activity in comparison with other B-cell lines and contain very low acidic sphingomyelinase activity. Purification of this activity from DT40 cell membranes suggested the presence of one major NSM isoform. Although complete purification of this isoform could not be achieved, partially purified fractions were examined further with regard to the known characteristics of previously partially purified NSMs and the two cloned enzymes exhibiting in vitro NSM activity (NSM1 and NSM2). For a direct comparative study, highly purified brain preparations, purified NSM1 protein and Bacillus cereus enzyme were used. Analysis of the enzymic properties of the partially purified DT40 NSM, such as cation dependence, substrate specificity, redox regulation and stimulation by phosphatidylserine, together with the localization of this enzyme to the endoplasmic reticulum (ER), suggested that this NSM from DT40 cells corresponds to NSM1. Further studies aimed to correlate presence of the high levels of this NSM1-like activity in DT40 cells with the ability of these cells to accumulate ceramide and undergo apoptosis. When DT40 cells were stimulated to apoptose by a variety of agents, including the ER stress, an increase in endogenous ceramide levels was observed. However, these responses were not enhanced compared with another B-cell line (Nalm-6), characterized by low sphingomyelinase activity. In addition, DT40 cells were not more susceptible to ceramide accumulation and apoptosis when exposed to the ER stress compared with other apoptotic agents. Inhibition of de novo synthesis of ceramide partially inhibited its accumulation, indicating that the ceramide production in DT40 cells could be complex and, under some conditions, could involve both sphingomyelin hydrolysis and ceramide synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071841      PMCID: PMC1222658          DOI: 10.1042/BJ20020120

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species.

Authors:  A C Fensome; F Rodrigues-Lima; M Josephs; H F Paterson; M Katan
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

Review 2.  Ceramide in the eukaryotic stress response.

Authors:  Y A Hannun; C Luberto
Journal:  Trends Cell Biol       Date:  2000-02       Impact factor: 20.808

3.  A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum.

Authors:  Y Neuberger; H Shogomori; Z Levy; M Fainzilber; A H Futerman
Journal:  FEBS Lett       Date:  2000-03-03       Impact factor: 4.124

4.  Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.

Authors:  K Hofmann; S Tomiuk; G Wolff; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.

Authors:  D Allan
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase.

Authors:  S Tomiuk; M Zumbansen; W Stoffel
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.

Authors:  K Bernardo; O Krut; K Wiegmann; D Kreder; M Micheli; R Schäfer; A Sickman; W E Schmidt; J M Schröder; H E Meyer; K Sandhoff; M Krönke
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

8.  Protective roles for ATM in cellular response to oxidative stress.

Authors:  N Takao; Y Li; K Yamamoto
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

9.  CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway.

Authors:  B Ségui; N Andrieu-Abadie; S Adam-Klages; O Meilhac; D Kreder; V Garcia; A P Bruno; J P Jaffrézou; R Salvayre; M Krönke; T Levade
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells.

Authors:  F M Uckun; K G Waddick; S Mahajan; X Jun; M Takata; J Bolen; T Kurosaki
Journal:  Science       Date:  1996-08-23       Impact factor: 47.728

View more
  4 in total

Review 1.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

2.  Calcium-independent phospholipase A2 (iPLA2 beta)-mediated ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) and mitochondria during ER stress-induced insulin-secreting cell apoptosis.

Authors:  Xiaoyong Lei; Sheng Zhang; Alan Bohrer; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

3.  The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.

Authors:  Xiaoyong Lei; Sheng Zhang; Alan Bohrer; Shunzhong Bao; Haowei Song; Sasanka Ramanadham
Journal:  Biochemistry       Date:  2007-08-09       Impact factor: 3.162

Review 4.  Vascular Smooth Muscle Cell Neutral Sphingomyelinase 2 in the Release of Exosomes and Vascular Calcification.

Authors:  Angelina Pavlic; Nasim Bahram Sangani; Johanna Kerins; Gerry Nicolaes; Leon Schurgers; Chris Reutelingsperger
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.